Other odontogenic markers at a relatively late stage such as DMP1, DSPP, and OCN were significantly expressed in the MBNs–NH2-treated groups from 14 or 21 days, as compared with the OM-treated control. The gene discussed is DMP1; the disease is ocular melanoma.